FGF23 and left ventricular hypertrophy: Elevated circulating concentrations of FGF23 have been implicated as a potential contributor to the development of congestive heart failure, left ventricular hypertrophy, atrial fibrillation, and hypertension, regardless of the presence or absence of impaired kidney function5–8.